a. Sino-Swed Breast Cancer SIDA Research Project.
b.Sino-Swed TK1 Pathology Research Project.
c. Sino-Swed 8-OxO-dG Research Project
Meanwhile, SSTK has been working with the following Sweden medical institutes;
Karolinska Institutes; Uppsala BMC; Stockholm University;
Also SSTK have been working with a couple of Chinese Medical institutes. Till now , SSTK has published more 10 pieces papers in SCI Journalsand more than 30 pieces papers upon TK1 clinical application in China.
Since Year 2014; SSTK Co-worked with the China foundation for the promotion of health , launched a national-wide research project, "The Application and Research for Thymidine Kinase 1(TK1) early Tumor Risk Assessment Technology”’. Meanwhile SSTK proposed a new solution for the application of TK1 named “1+X”which is a Early tumor risk screening project, Since then SSTK has worked closely with several China medical institutes to expand the application of TK1 for different types of tumors and health screening ; which provide new concepts for the Heath Management and cancer prevention and control.